Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

1,127

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

June 30, 2024

Conditions
CarcinomaSleep Disorder
Interventions
DRUG

Yangzheng Compound Mixture

"At the end of the treatment period, the investigator can decide whether to continue the medication based on the improvement of the subjects' sleep disturbance.~Medication during the follow-up period: subjects will enter the follow-up period after completing one course of Yangzheng Compound Mixture treatment or the end of the treatment period. Visits will be conducted once every 3 weeks, at least 2 times and no more than 4 times. For subjects in the experimental group, doctors can decide whether the patients should continue to receive Yangzheng Compound Mixture therapy in the follow-up period according to the improvement of sleep disorders, while for subjects in the control group, the patients can choose to start receiving Yangzheng Compound Mixture therapy in the follow-up period according to their own wishes and doctors' suggestions."

OTHER

Conventional Treatment

Including treatment of sleep disorders and tumor which shall follow the clinical guidelines.

Trial Locations (10)

210203

Shuguang Hospital Affiliated with Shanghai University of TCM, Shanghai

410005

The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha

Unknown

Chongqing University Cancer Hospital, Chongqing

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin

Jiamusi Cancer Hospital, Jiamusi

Henan Cancer Hospital, Zhengzhou

The Third Affiliated Hospital of Shandong First Medical University, Jinan

Zhongshan Hospital, Shanghai

Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang

Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

collaborator

Shaanxi Buchang Pharmaceutical Co., Ltd

INDUSTRY

lead

ShuGuang Hospital

OTHER